These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 24099550)

  • 1. Influence of alkalizers on dissolution properties of telmisartan in solid dispersions prepared by cogrinding.
    Zhong L; Zhu X; Yu B; Su W
    Drug Dev Ind Pharm; 2014 Dec; 40(12):1660-9. PubMed ID: 24099550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of microenvironmental pH and crystallinity of ionizable telmisartan using alkalizers in solid dispersions for controlled release.
    Tran PH; Tran HT; Lee BJ
    J Control Release; 2008 Jul; 129(1):59-65. PubMed ID: 18501462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissolution properties and physical characterization of telmisartan-chitosan solid dispersions prepared by mechanochemical activation.
    Zhong L; Zhu X; Luo X; Su W
    AAPS PharmSciTech; 2013 Jun; 14(2):541-50. PubMed ID: 23430728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation and correlation of physical stability, dissolution behaviour and interaction parameter of amorphous solid dispersions of telmisartan: a drug development perspective.
    Dukeck R; Sieger P; Karmwar P
    Eur J Pharm Sci; 2013 Jul; 49(4):723-31. PubMed ID: 23684913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fabrication and evaluation of pH-modulated solid dispersion for telmisartan by spray-drying technique.
    Marasini N; Tran TH; Poudel BK; Cho HJ; Choi YK; Chi SC; Choi HG; Yong CS; Kim JO
    Int J Pharm; 2013 Jan; 441(1-2):424-32. PubMed ID: 23174408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solubilization of the poorly water soluble drug, telmisartan, using supercritical anti-solvent (SAS) process.
    Park J; Cho W; Cha KH; Ahn J; Han K; Hwang SJ
    Int J Pharm; 2013 Jan; 441(1-2):50-5. PubMed ID: 23262425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of microenvironmental pH and utilization of alkalizers in crystalline solid dispersion for enhanced solubility and stability of clarithromicin.
    Park JB; Park YJ; Kang CY; Lee BJ
    Arch Pharm Res; 2015; 38(5):839-48. PubMed ID: 25213008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissolution-enhancing mechanism of alkalizers in poloxamer-based solid dispersions and physical mixtures containing poorly water-soluble valsartan.
    Ha NS; Tran TT; Tran PH; Park JB; Lee BJ
    Chem Pharm Bull (Tokyo); 2011; 59(7):844-50. PubMed ID: 21720034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tablet Formulation of a Polymeric Solid Dispersion Containing Amorphous Alkalinized Telmisartan.
    Chae JS; Chae BR; Shin DJ; Goo YT; Lee ES; Yoon HY; Kim CH; Choi YW
    AAPS PharmSciTech; 2018 Oct; 19(7):2990-2999. PubMed ID: 30043191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amorphous ternary cyclodextrin nanocomposites of telmisartan for oral drug delivery: improved solubility and reduced pharmacokinetic variability.
    Sangwai M; Vavia P
    Int J Pharm; 2013 Sep; 453(2):423-32. PubMed ID: 22935741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of MgO release from polyethylene glycol 6000-based solid dispersions on microenvironmental pH, enhanced dissolution and reduced gastrointestinal damage of telmisartan.
    Tran PH; Tran TT; Lee SA; Nho VH; Chi SC; Lee BJ
    Arch Pharm Res; 2011 May; 34(5):747-55. PubMed ID: 21656360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced gastric stability of esomeprazole by molecular interaction and modulation of microenvironmental pH with alkalizers in solid dispersion.
    Van Nguyen H; Baek N; Lee BJ
    Int J Pharm; 2017 May; 523(1):189-202. PubMed ID: 28342789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissolution-modulating mechanism of alkalizers and polymers in a nanoemulsifying solid dispersion containing ionizable and poorly water-soluble drug.
    Tran TT; Tran PH; Lee BJ
    Eur J Pharm Biopharm; 2009 May; 72(1):83-90. PubMed ID: 19141319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of fixed dose combination and physicochemical characterization of enteric-coated bilayer tablet with circadian rhythmic variations containing telmisartan and pravastatin sodium.
    Luo D; Kim JH; Park C; Oh E; Park JB; Cui JH; Cao QR; Lee BJ
    Int J Pharm; 2017 May; 523(1):343-356. PubMed ID: 28330645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extensive Diminution of Particle Size and Amorphization of a Crystalline Drug Attained by Eminent Technology of Solid Dispersion: A Comparative Study.
    Singh G; Sharma S; Gupta GD
    AAPS PharmSciTech; 2017 Jul; 18(5):1770-1784. PubMed ID: 27766512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid dispersion prepared by continuous cogrinding in an air jet mill.
    Muehlenfeld C; Kann B; Windbergs M; Thommes M
    J Pharm Sci; 2013 Nov; 102(11):4132-9. PubMed ID: 24105729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of telmisartan tablets prepared via the wet granulation method and pritor™ prepared using the spray-drying method.
    Park J; Park HJ; Cho W; Cha KH; Yeon W; Kim MS; Kim JS; Hwang SJ
    Arch Pharm Res; 2011 Mar; 34(3):463-8. PubMed ID: 21547679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism and Improved Dissolution of Glycyrrhetinic Acid Solid Dispersion by Alkalizers.
    Dong L; Mai Y; Liu Q; Zhang W; Yang J
    Pharmaceutics; 2020 Jan; 12(1):. PubMed ID: 31968604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of amorphization method on telmisartan solubility and the tableting process.
    Lepek P; Sawicki W; Wlodarski K; Wojnarowska Z; Paluch M; Guzik L
    Eur J Pharm Biopharm; 2013 Jan; 83(1):114-21. PubMed ID: 23085331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.